חזרה לתוצאות החיפוש

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Cardiogenic Shock

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • CHRU Strasbourg -Nouvel Hôpital Civil, Strasbourg, Bas-Rhin, France

    Contact: Study coordinator (Ferhat MEZIANI, MD-PhD)
    Contact: Principal Investigator (Ferhat MEZIANI, MD-PhD)

  • AP-HM, Nord Hospital, Marseille, Marseille, Bouches du Rhône, France

    Contact: Study coordinator (Laurent Bonello, MD)
    Contact: Principal Investigator (Laurent Bonello, MD)

  • CHU Caen, Caen, Calvados, France

    Contact: Study coordinator (Katrien Blanchart, MD)
    Contact: Principal Investigator (Katrien Blanchart, MD)

  • CHU Dijon, Dijon, Côte d'Or, France

    Contact: Study coordinator (Jean-Pierre Quenot, MD-PhD)
    Contact: Principal Investigator (Jean-Pierre Quenot, MD-PhD)

  • CHU Besançon Jean Minjoz Hospital, Besançon, Doubs, France

    Contact: Study coordinator (Hadrien WINISZEWSKI, MD)
    Contact: Principal Investigator (Hadrien WINISZEWSKI, MD)

  • CHU Nîmes, Carémeau Hospital, Nîmes, Gard, France

    Contact: Study coordinator (Benoît Lattuca, MD)
    Contact: Principal Investigator (Benoît Lattuca, MD)

  • CHU Bordeaux - Hopital haut-leveque, Bordeaux, Gironde, France

    Contact: Study coordinator (Edouard Gerbaud, MD)
    Contact: Principal Investigator (Edouard Gerbaud, MD)

  • CHU de Toulouse, Toulouse, Haute-Garonne, France

    Contact: Study coordinator (Clément Delmas, MD)
    Contact: Principal Investigator (Clément Delmas, MD)

  • CHU Limoges, Dupuytren Hospital, Limoges, Haute-Vienne, France

    Contact: Study coordinator (Philippe Vignon, MD)
    Contact: Principal Investigator (Philippe Vignon, MD)

  • CHU Montpellier, Arnaud de Villeneuve Hospital, Montpellier, Hérault, France

    Contact: Study coordinator (François Roubille, MD)
    Contact: Principal Investigator (François Roubille, MD)

  • CHU Rennes, Pontchaillou Hospital, Rennes, Ille et Vilaine, France

    Contact: Study coordinator (Abdelkader BAKHTI, MD)
    Contact: Principal Investigator (Abdelkader BAKHTI, MD)

  • CHU Grenoble, Michallon Hospital, La Tronche, Isère, France

    Contact: Study coordinator (Joanna Bougnaud, MD)
    Contact: Principal Investigator (Joanna Bougnaud, MD)

  • CHU Nantes, Nantes, Loire-Atlantique, France

    Contact: Study coordinator (Julien Plessis, MD)
    Contact: Principal Investigator (Julien Plessis, MD)

  • CHR Metz-Thionville, Mercy Hospital, Ars-Laquenexy, Moselle, France

    Contact: Study coordinator (Guillaume Louis, MD)
    Contact: Principal Investigator (Guillaume Louis, MD)

  • CHRU Lille, Cœur Poumon Institute, Lille, Nord, France

    Contact: Study coordinator (Gilles LEMESLE, MD-PhD)
    Contact: Principal Investigator (Gilles LEMESLE, MD-PhD)

  • APHP, La Pitié Salpêtrière (medical intensive care unit), Paris, Paris, France

    Contact: Study coordinator (Alain Combes, MD)
    Contact: Principal Investigator (Alain Combes, MD)

  • Hospices Civils de Lyon - Louis Pradel Hospital, Bron, Rhône, France

    Contact: Study coordinator (Bertrand SCHEPPLER, MD) · bertrand.scheppler01@chu-lyon.fr · +33 4 72 11 80 88
    Contact: Principal Investigator (Bertrand SCHEPPLER, MD)

  • APHP, Henri Mondor Hospital, Créteil, Val de Marne, France

    Contact: Study coordinator (Raphaëlle HUGUET, MD) · raphaelle.huguet@aphp.fr · +33 1 49 81 21 11
    Contact: Principal Investigator (Raphaelle HUGUET, MD)

  • CH Henri Duffaut, Avignon, Avignon, Vaucluse, France

    Contact: Study coordinator (Stéphane Andrieu, MD)
    Contact: Principal Investigator (Stéphane Andrieu, MD)

  • CHU Bordeaux, Bordeaux, France

    Contact: Study coordinator (Alexandre OUTARRA, MD-PhD)
    Contact: Principal Investigator (Alexandre OUTARRA, Md-PhD)

  • HENRI MONDOR -réanimation, Créteil, France

    Contact: Study coordinator (Armand MEKONTSO DESSAP, MD-Phd) · armand.dessap@aphp.fr · +33 1 49 81 21 11
    Contact: Principal Investigator (Armand MEKONTSO DESSAP, MD-PhD)

  • Chu Dijon, Dijon, France

    Contact: Study coordinator (Pierre Grégoire GUINOT, MD-PhD)
    Contact: Principal Investigator (Pierre Grégoire GUINOT, MD-PhD)

  • CHU Grenoble -USIC, La Tronche, France

    Contact: Study coordinator (Nicolas PILIERO, MD)
    Contact: Principal Investigator (Nicolas PILIERO, MD)

  • AP-HM CHU la Timone, Marseille, France

    Contact: Study coordinator (Florent ARREGLE, MD)
    Contact: Principal Investigator (Florent ARREGLE, MD)

  • CHU Montpellier -hôpital Arnaud de Villeneuve, Montpellier, France

    Contact: Study coordinator (Philippe GAUDARD, MD-PhD)
    Contact: Principal Investigator (Philippe GAUDARD, MD-PhD)

  • Chu Rouen, Rouen, France

    Contact: Study coordinator (Emmanuel BESNIER, MD-PhD)
    Contact: Principal Investigator (Emmanuel BESNIER, MD-PhD)

  • HU Strasbourg USIC, Strasbourg, France

    Contact: Study coordinator (Olivier MOREL, MD PhD) · olivier.morel@chru-strasbourg.fr · +33 3 88 11 67 68
    Contact: Principal Investigator (Olivier MOREL, MD-pHD)

  • CHRU Nancy, Vandœuvre-lès-Nancy, France

    Contact: Study coordinator (Bruno Lévy, Prof)
    Contact: Principal Investigator (Bruno LEVY, Prof)
מובילי המחקר

  • Clément DELMAS, Dr

    Study Chair

    University Hospital, Toulouse

  • Nicolas GIRERD, Pr

    Study Chair

    CHRU Nancy

  • Patrick ROSSIGNOL, Pr

    Study Chair

    CHRU Nancy

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)